Frederick Beddingfield is the founder of Kira Pharmaceuticals. Kira Pharmaceuticals has raised $46M in total funding. Latest round: Series B.
Frederick Beddingfield is the Chief Executive Officer of Kira Pharmaceuticals, a global biotechnology company focused on developing complement-targeted therapies for immune-mediated diseases. The company uses its LOGIC drug discovery platform to advance its pipeline. Kira Pharmaceuticals recently completed a $53.5 million Series B+ financing round, building on previous Series A and Series B funding rounds. Beddingfield previously served as the CEO of Sienna Biopharmaceuticals.
Full founder directory · Investor directory · Company funding database · Fundraising library